CYP2C9 is an important enzyme in the pharmacogenomics of cardiovascular diseases and therefore a potential priority pharmacogene in Africans in Southern Africa, where cardiovascular disorders are a growing burden. The gene discussed is CYP2C9; the disease is cardiovascular disorder.